REGN
REGENERON PHARM
Health Care·Biotechnology·UNITED STATES
$826.64
MCap $85.1B
as of 2026-08-20
Total
B1w
Fund
C9w
Quant
B1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-0.54
Sentiment 82.3%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$826.64
Adaptive Mean
$839.23
-12.59 vs mean
Adaptive σ
11.67
MIDOS BB
$815.89 – $862.57
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
+0.06
ROE
14.0%
Z +0.49
Rev Gr
16.7%
Z -0.14
EPS Gr
-4.5%
Z -0.06
OPM Gr
3.7%
Z -0.42
FCF Yld
3.5%
Z +0.39
EPS Surp
0.4%
Z -0.03
EPS 3mo Δ
35.2%
Z +0.19
Fwd P/E
13.89
Z —
PEGY
0.34
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
19.33
Q6M
0.21
Q12M
5.66
MA 30/100
1.053
Bullish (MA30 > MA100)
α (Jensen)
0.9442
β (12M)
0.49
σ (12M)
0.336
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
62%
Q Percentile
81%
Divergence
-19.3
Tier
TRIM — WATCH
Momentum ahead of fundamentals.
Kirkpatrick RS & Persistence
RS
-9.0
RS Pctl
47%
RS Decile
D5
Persistence
1w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.